Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
INAB
$1.14
+4.59%
INAB
· In8bio, Inc.
$1.14
+0.05 (+4.59%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's business strategy, its existing cash of $18.0 million as of June 30, 2026 is not anticipated to fund the Company's projected operating expenses and capital expenditure requirements for a period of at least 12 months from the date of issuance of these condensed financial statements, and accordingly, there is substantial doubt about the Company's ability to continue to operate as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$11.24M
Shares
9.86M
Volume · Oct 20
2378
Avg daily vol (3M)
53.67K
All webcasts
Earnings call · FY2023 Q3
In8bio, Inc. (INAB) Q3 2023 Earnings Call
Diluted EPS
-$6.90
Net income
-$7.17M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2023 · complete as-filed document